Table of Contents Author Guidelines Submit a Manuscript
Behavioural Neurology
Volume 2014 (2014), Article ID 294149, 6 pages
http://dx.doi.org/10.1155/2014/294149
Research Article

Inhibitory Effect of NMDA Receptors in the Ventral Tegmental Area on Hormonal and Eating Behavior Responses to Stress in Rats

1Department of Biology, Faculty of Biological Science, North Tehran Branch, Islamic Azad University, Tehran 19395-6558, Iran
2Neuroscience Research Center, Baqiyatallah (a.s.) University of Medical Sciences, Tehran 19395-6558, Iran
3Faculty of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran 19395-6558, Iran
4Department of Physiology and Biophysics, Faculty of Medicine, Baqiyatallah (a.s.) University of Medical Sciences, Tehran 19395-6558, Iran

Received 9 February 2014; Revised 29 June 2014; Accepted 22 July 2014; Published 7 August 2014

Academic Editor: Antonio Pisani

Copyright © 2014 Zohreh Sadat Nasihatkon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Roozendaal, B. S. McEwen, and S. Chattarji, “Stress, memory and the amygdala,” Nature Reviews Neuroscience, vol. 10, no. 6, pp. 423–433, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Wang, S. Fanous, E. F. Terwilliger, C. E. Bass, R. P. Hammer Jr., and E. M. Nikulina, “BDNF over expression in the ventral tegmental area prolongs social defeat stress-induced crosssensitization to amphetamine and increases ΔFosB expression in mesocorticolimbic regionsof rats,” Neuropsychopharmacology, vol. 38, no. 11, pp. 2286–2296, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. K. A. Butts and A. G. Phillips, “Glucocorticoid receptors in the prefrontal cortex regulate dopamine efflux to stress via descending glutamatergic feedback to the ventral tegmental area,” International Journal of Neuropsychopharmacology, vol. 16, no. 8, pp. 1799–1807, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. M. J. Wanat, A. Bonci, and P. E. M. Phillips, “CRF acts in the midbrain to attenuate accumbens dopamine release to rewards but not their predictors,” Nature Neuroscience, vol. 16, no. 4, pp. 383–385, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. J. L. Niehaus, M. Murali, and J. A. Kauer, “Drugs of abuse and stress impair LTP at inhibitory synapses in the ventral tegmental area,” European Journal of Neuroscience, vol. 32, no. 1, pp. 108–117, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. S. S. Daftary, J. Panksepp, Y. Dong, and D. B. Saal, “Stress-induced, glucocorticoid-dependent strengthening of glutamatergic synaptic transmission in midbrain dopamine neurons,” Neuroscience Letters, vol. 452, no. 3, pp. 273–276, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Tagliaferro and M. Morales, “Synapses between corticotropin-releasing factor-containing axon terminals and dopaminergic neurons in the ventral tegmental area are predominantly glutamatergic,” Journal of Comparative Neurology, vol. 506, no. 4, pp. 616–626, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. A. Kauer, “Addictive drugs and stress trigger a common change at VTA synapses,” Neuron, vol. 37, no. 4, pp. 549–550, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. M. D. Doherty and A. Gratton, “NMDA receptors in nucleus accumbens modulate stress-induced dopamine release in nucleus accumbens and ventral tegmental area,” Synapse, vol. 26, no. 3, pp. 225–234, 1997. View at Google Scholar
  10. K. Wedzony, A. Chocyk, W. Kolasiewicz, and M. Maćkowiak, “Glutamatergic neurons of rat medial prefrontal cortex innervating the ventral tegmental area are positive for serotonin 5-HT1A receptor protein,” Journal of Physiology and Pharmacology, vol. 58, no. 4, pp. 611–624, 2007. View at Google Scholar · View at Scopus
  11. P. Enrico, M. Bouma, J. B. de Vries, and B. H. C. Westerink, “The role of afferents to the ventral tegmental area in the handling stress-induced increase in the release of dopamine in the medial prefrontal cortex: a dual-probe microdialysis study in the rat brain,” Brain Research, vol. 779, no. 1-2, pp. 205–213, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Moore, H. J. Rose, and A. A. Grace, “Chronic cold stress reduces the spontaneous activity of ventral tegmental dopamine neurons,” Neuropsychopharmacology, vol. 24, no. 4, pp. 410–419, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Rodaros, D. A. Caruana, S. Amir, and J. Stewart, “Corticotropin-releasing factor projections from limbic forebrain and paraventricular nucleus of the hypothalamus to the region of the ventral tegmental area,” Neuroscience, vol. 150, no. 1, pp. 8–13, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. M. J. Wanat, F. W. Hopf, G. D. Stuber, P. E. M. Phillips, and A. Bonci, “Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih,” Journal of Physiology, vol. 586, no. 8, pp. 2157–2170, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Tomie, A. S. Aguado, L. A. Pohorecky, and D. Benjamin, “Individual differences in pavlovian autoshaping of lever pressing in rats predict stress-induced corticosterone release and mesolimbic levels of monoamines,” Pharmacology Biochemistry and Behavior, vol. 65, no. 3, pp. 509–517, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Dziedzicka-Wasylewska, P. Willner, and M. Papp, “Changes in dopamine receptor mRNA expression following chronic mild stress and chronic antidepressant treatment,” Behavioural Pharmacology, vol. 8, no. 6-7, pp. 607–618, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. L. W. Fitzgerald, J. Ortiz, A. G. Hamedani, and E. J. Nestler, “Drugs of abuse and stress increase the expression of GIuRI and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents,” Journal of Neuroscience, vol. 16, no. 1, pp. 274–282, 1996. View at Google Scholar · View at Scopus
  18. M. G. P. Feenstra, A. Kalsbeek, and H. Van Galen, “Neonatal lesions of the ventral tegmental area affect monoaminergic responses to stress in the medial prefrontal cortex and other dopamine projection areas in adulthood,” Brain Research, vol. 596, no. 1-2, pp. 169–182, 1992. View at Publisher · View at Google Scholar · View at Scopus
  19. C. D. Kilts, M. L. Coco, T. D. Ely, G. Bissette, and C. B. Nemeroff, “Differential effects of conditioned and unconditioned stress on the neurotensin content of dopamine cell body groups of the ventral mesencephalon,” Annals of the New York Academy of Sciences, vol. 668, no. 1, pp. 266–276, 1992. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Kaneyuki, H. Yokoo, A. Tsuda et al., “Psychological stress increases dopamine turnover selectively in mesoprefrontal dopamine neurons of rats: reversal by diazepam,” Brain Research, vol. 557, no. 1-2, pp. 154–161, 1991. View at Publisher · View at Google Scholar · View at Scopus
  21. P. W. Kalivas, P. Duffy, and L. G. Latimer, “Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat,” Journal of Pharmacology and Experimental Therapeutics, vol. 242, no. 3, pp. 757–763, 1987. View at Google Scholar · View at Scopus
  22. G. Z. Réus, R. B. Stringari, T. R. Kirsch et al., “Neurochemical and behavioural effects of acute and chronic memantine administration in rats: further support for NMDA as a new pharmacological target for the treatment of depression?” Brain Research Bulletin, vol. 81, no. 6, pp. 585–589, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Z. Réus, H. M. Abelaira, R. B. Stringari, G. R. Fries, F. Kapczinski, and J. Quevedo, “Memantine treatment reverses anhedonia, normalizes corticosterone levels and increases BDNF levels in the prefrontal cortex induced by chronic mild stress in rats,” Metabolic Brain Disease, vol. 27, no. 2, pp. 175–182, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Babic, M. Ondrejcakova, J. Bakos, E. Racekova, and D. Jezova, “Cell proliferation in the hippocampus and in the heart is modified by exposure to repeated stress and treatment with memantine,” Journal of Psychiatric Research, vol. 46, no. 4, pp. 526–532, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Sani, G. Serra, G. D. Kotzalidis et al., “The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence,” CNS Drugs, vol. 26, no. 8, pp. 663–690, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. B. H. Harvey, T. Bothma, A. Nel, G. Wegener, and D. J. Stein, “Involvement of the NMDA receptor, NO-cyclic GMP and nuclear factor K-β in an animal model of repeated trauma,” Human Psychopharmacology, vol. 20, no. 5, pp. 367–373, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M. A. Battista, R. Hierholzer, H. R. Khouzam, A. Barlow, and S. O'Toole, “Pilot trial of memantine in the treatment of posttraumatic stress disorder,” Psychiatry, vol. 70, no. 2, pp. 167–174, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. Z. Hooshmandi, A. H. Rohani, A. Eidi, Z. Fatahi, L. Golmanesh, and H. Sahraei, “Reduction of metabolic and behavioral signs of acute stress in male Wistar rats by saffron water extract and its constituent safranal,” Pharmaceutical Biology, vol. 49, no. 9, pp. 947–954, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Paxinos and D. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, NY, USA, 2nd edition, 1987.
  30. E. S. Brown, M. Vazquez, and A. Nakamura, “Randomized, placebo-controlled, crossover trial of memantine for cognitive changes with corticosteroid therapy,” Biological Psychiatry, vol. 64, no. 8, pp. 727–729, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Tokita, Y. Fujita, T. Yamaji, and K. Hashimoto, “Depressive-like behavior in adrenocorticotropic hormone-treated rats blocked by memantine,” Pharmacology Biochemistry and Behavior, vol. 102, no. 2, pp. 329–334, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Zhou, V. P. Yuferov, R. Spangler, C. E. Maggos, A. Ho, and M. J. Kreek, “Effects of memantine alone and with acute “binge” cocaine on hypothalamic-pituitary-adrenal activity in the rat,” European Journal of Pharmacology, vol. 352, no. 1, pp. 65–71, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. Z. Pirnik, M. Schwendt, and D. Jezova, “Single dose of morphine influences plasma corticosterone and gene expression of main NMDA receptor subunit in the adrenal gland but not in the hippocampus,” Endocrine Regulations, vol. 35, no. 4, pp. 187–193, 2001. View at Google Scholar · View at Scopus